Nu Skin Enterprises (NUS) Set to Announce Earnings on Wednesday

Nu Skin Enterprises (NYSE:NUS) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Wednesday, February 14th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The company had revenue of $488.64 million for the quarter, compared to analyst estimates of $479.35 million. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nu Skin Enterprises Stock Performance

NYSE:NUS opened at $12.20 on Tuesday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.28 and a current ratio of 2.13. The stock’s fifty day moving average is $12.66 and its 200 day moving average is $15.97. Nu Skin Enterprises has a fifty-two week low of $11.73 and a fifty-two week high of $39.12. The firm has a market capitalization of $602.94 million, a PE ratio of 67.78 and a beta of 1.13.

Nu Skin Enterprises Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Shareholders of record on Monday, February 26th were paid a $0.06 dividend. The ex-dividend date was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a yield of 1.97%. Nu Skin Enterprises’s payout ratio is 133.33%.

Analyst Ratings Changes

Separately, StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus price target of $23.67.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.